Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Business > Anticipating Future Risks in the New World

Tags

  • ability
  • would
  • device
  • biological product
  • these exposures

  • Links

  • The Medical Informer
  • Secrets of a One-Match Fireplace Fire
  • Save Money on Gasoline
  • Digg It - Anticipating Future Risks in the New World

    Technology is taking us into the future at a pace that is faster than we previously imagined possible. Our ability to conjure an image of what the world may look like five to
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ten years down the track is improving, thanks to new strategic planning theories and tools. However, it is our willingness to consider emerging, new categories of risk that
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    is still a stumbling block for many business planners. Some executives and business owners are “risk adverse”, preferring to deal with a business interruption as and when it
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    occurs. Yet it is through the discipline of Risk Management that we can improve our ability to survive in the cutthroat world of the modern economy. Risk management, when em
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ployed as an integral part of business operations, can improve both the quality and reliability of technology and how it is applied in real life.

    Most risk assessments revolv
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ng around cyberspace take place after an event occurs. This is possibly because many executives are still grappling with what is and isn’t possible via the World Wide Web. T
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    he value, then, of Risk Management as a strategic tool, becomes more apparent as we push at the boundaries of commerce, law and privacy.

    Security Managers and purveyors of IT
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    security tools are observing the birth of new types of cyber exposures. Many of these exposures appear around digital preservation, IP address volatility, cyber harassment c
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    laims, privacy, hacker attacks, liability for theft of non-owned data and loss or corruption of intangible assets (such as process design theory and other intellectual propert
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    y). Executives and business owners wanting to continue conducting business via the web, need to educate themselves regarding what these exposures mean for their company and t
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    eir ability to do business, and their customer’s trust in using the web for financial transactions.

    The developing cyber world is helping create new industries that can assis
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    t in mitigating these risk areas. Opportunity knocks, but we only open the door if we recognise the caller. Wouldn’t it be nice to anticipate these new technology related ex
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    posures, recognise the mitigation when it calls at the door and be in a position to offer it a nice cup of tea?

    We can begin realising future risk by asking, “What will the w
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    orld look like ten years hence and how will technology be serving us?” Don’t limit yourself to imagining only what your business will be like, because it is also necessary to
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    imagine what kind of customers we may be serving, what their needs may be and how the prefer to communicate with us.

    The integration of digital and material technologies cou
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    d give birth to exciting new possibility for improvements in medicine, education and communication. Cyber villages and cyber nomads have begun appearing and are expected to b
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ecome more prevalent in the new technological cyber reality – creating new business and marketing opportunities. The emergent sub-world supporting these developments, referre
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    d to as “Deep Place” by the Institute of the Future, is where it becomes vitally important that we focus our protective strategies. This is where technology, policies, data r
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    epositories and skills supporting the new world reside. We must anticipate: “What must we do in order to preserve and support this new ecology?”

    When we acknowledge and acce
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    pt both the potential and value of our new culture and become willing to protect it, we will discover that Future Risk Management is our friend and ally in the brave new world


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/4600/diggit-Anticipating-Future-Risks-in-the-New-World.html">Anticipating Future Risks in the New World</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/4600/diggit-Anticipating-Future-Risks-in-the-New-World.html]Anticipating Future Risks in the New World[/url]

    Related Articles:

    Packaging Services

    Cardboard Shredders

    Why Taking Care of Cleaning Equipment Adds to the Bottom Line

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com